Continuous low pH viral inactivation: Operation and scaling strategy informs viral clearance study
- PMID: 35470424
- DOI: 10.1002/bit.28117
Continuous low pH viral inactivation: Operation and scaling strategy informs viral clearance study
Abstract
A continuous viral inactivation (CVI) tubular reactor was designed for low pH viral inactivation within a continuous downstream system across multiple scales of operation. The reactors were designed to provide a minimum residence time of >60 min. The efficacy of this tubular reactor was tested with xenotropic murine leukemia virus (X-MuLV) through pulse injection experiments. It was determined that the minimum residence time of the small-scale reactor design, when operated at the target process flow rate, occurred between 63 and 67 min. Inactivation kinetics were compared between continuous operation and standard batch practices using three monoclonal antibodies. The quantification of the virus log reduction values (LRV) was similar between the two modes of operation and most of the acid-treated samples had virus concentrations below the limit of detection. However, residual infectivity was still present in the endpoint batch samples of two experiments while the continuous samples always remained below the limit of detection. This provides the foundation for leveraging a standard batch-based model to quantify the LRV for a CVI unit operation.
Keywords: Dean vortices; continuous manufacturing; scale down; scale up; viral inactivation.
© 2022 Wiley Periodicals LLC.
Similar articles
-
Leveraging flow mechanics to determine critical process and scaling parameters in a continuous viral inactivation reactor.Biotechnol Bioeng. 2020 Mar;117(3):637-645. doi: 10.1002/bit.27223. Epub 2019 Nov 19. Biotechnol Bioeng. 2020. PMID: 31709510
-
Virus study for continuous low pH viral inactivation inside a coiled flow inverter.Biotechnol Bioeng. 2019 Apr;116(4):857-869. doi: 10.1002/bit.26872. Epub 2018 Dec 31. Biotechnol Bioeng. 2019. PMID: 30450694
-
Truly continuous low pH viral inactivation for biopharmaceutical process integration.Biotechnol Bioeng. 2020 May;117(5):1406-1417. doi: 10.1002/bit.27292. Epub 2020 Feb 24. Biotechnol Bioeng. 2020. PMID: 32017010 Free PMC article.
-
Viral Inactivation: Low pH and Detergent.PDA J Pharm Sci Technol. 2015 Jan-Feb;69(1):163-72. doi: 10.5731/pdajpst.2015.01040. PDA J Pharm Sci Technol. 2015. PMID: 25691724 Review. No abstract available.
-
Integrated viral clearance strategies-reflecting on the present, projecting to the future.Curr Opin Biotechnol. 2018 Oct;53:137-143. doi: 10.1016/j.copbio.2018.01.003. Epub 2018 Jan 23. Curr Opin Biotechnol. 2018. PMID: 29367164 Review.
References
REFERENCES
-
- ASTM. (2012). E2888-12: standard practice for process for inactivation of rodent retrovirus by pH. ASTM International. https://www.astm.org
-
- Brorson, K., Krejci, S., Lee, K., Hamilton, E., Stein, K., & Xu, Y. (2003). Bracketed generic inactivation of rodent retroviruses by low pH treatment for monoclonal antibodies and recombinant proteins. Biotechnology and Bioengineering, 82(3), 321-329. https://doi.org/10.1002/bit.10574
-
- Brown, M. R., & Orozco, R. (2021). Utilizing bacteriophage to define the minimum residence time within a plug flow reactor. Biotechnology Bioengineering, 1-8. https://doi.org/10.1002/bit.27734
-
- Brown, M. R., Orozco, R., & Coffman, J. (2020). Leveraging flow mechanics to determine critical process and scaling parameters in a continuous viral inactivation reactor. Biotechnology and Bioengineering, 117(3), 637-645. https://doi.org/10.1002/bit.27223
-
- Chinniah, S., Hinckley, P., & Connell-Crowley, L. (2016). Characterization of operating parameters for XMuLV inactivation by low pH treatment. Biotechnology Progress, 32(1), 89-97. https://doi.org/10.1002/btpr.2183
MeSH terms
LinkOut - more resources
Full Text Sources